Chengzhang Fu

Chengzhang Fu

Auto-generated profile, based on publicly available information

Chengzhang Fu

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy Saarland University Saarbrücken Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2019 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
LHLiujie Huo
Liujie Huo
JHJoachim Hug
Joachim Hug
CFChengzhang Fu
Chengzhang Fu
XBXiaoying Bian
Xiaoying Bian
YZYouming Zhang
Youming Zhang
RMRolf Müller
Rolf Müller
The review highlights the 2013–2018 literature on the heterologous expression of bacterial natural product biosynthetic pathways and emphasises new techniques, heterologous hosts, and novel chemistry.

13 March 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
LZLixin Zhang
Lixin Zhang
KYKezhi Yan
Kezhi Yan
YZYu Zhang
Yu Zhang
RHRen Huang
Ren Huang
JBJiang Bian
Jiang Bian
XCXiaoping Chen
Xiaoping Chen
The high mortality rate of immunocompromised patients with fungal infections and the limited availability of highly efficacious and safe agents demand the development of new antifungal therapeutics. To rapidly discover such agents, we developed a high-throughput synergy screening (HTSS) strategy for novel microbial natural products. Specifically, a microbial natural product library was screened for hits that synergize the effect of a low dosage of ketoconazole (KTC) that alone shows little detectable fungicidal activity. Through screening of ≈20,000 microbial extracts, 12 hits were identified with broad-spectrum antifungal activity. Seven of them showed little cytotoxicity against human hepatoma cells. Fractionation of the active extracts revealed beauvericin (BEA) as the most potent component, because it dramatically synergized KTC activity against diverse fungal pathogens by a checkerboard assay. Significantly, in our immunocompromised mouse model, combinations of BEA (0.5 mg/kg) and KTC (0.5 mg/kg) prolonged survival of the host infected with Candida parapsilosis and reduced fungal colony counts in animal organs including kidneys, lungs, and brains. Such an effect was not achieved even with the high dose of 50 mg/kg KTC. These data support synergism between BEA and KTC and thereby a prospective strategy for antifungal therapy.

16 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
CFChengzhang Fu
Chengzhang Fu
ASAsfandyar Sikandar
Asfandyar Sikandar
JDJannik Donner
Jannik Donner
NZNestor Zaburannyi
Nestor Zaburannyi
JHJennifer Herrmann
Jennifer Herrmann
RMRolf Müller
Rolf Müller
The natural product carolacton is a macrolide keto-carboxylic acid produced by the myxobacteriumSorangium cellulosum, and was originally described as an antibacterial compound. Here we show that carolacton targets FolD, a key enzyme from the folate-dependent C1 metabolism. We characterize the interaction between bacterial FolD and carolacton biophysically, structurally and biochemically. Carolacton binds FolD with nanomolar affinity, and the crystal structure of the FolD–carolacton complex reveals the mode of binding. We show that the human FolD orthologs, MTHFD1 and MTHFD2, are also inhibited in the low nM range, and that micromolar concentrations of carolacton inhibit the growth of cancer cell lines. As mitochondrial MTHFD2 is known to be upregulated in cancer cells, it may be possible to use carolacton as an inhibitor tool compound to assess MTHFD2 as an anti-cancer target.

1 May 2010 in FEMS Microbiology Ecology
Verified
Journal Article
Open access
PDF file
YHYongfei Hu
Yongfei Hu
CFChengzhang Fu
Chengzhang Fu
YHYunpeng Huang
Yunpeng Huang
YYYeshi Yin
Yeshi Yin
GCGong Cheng
Gong Cheng
BZBaoli Zhu
Baoli Zhu
Metagenomic cloning is a powerful tool for the discovery of novel genes and biocatalysts from environmental microorganisms. Based on activity screenin

28 April 2012 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
CCCaixia Chen
Caixia Chen
FSFuhang Song
Fuhang Song
QWQian Wang
Qian Wang
WAWael Abdel-Mageed
Wael Abdel-Mageed
HGHui Guo
Hui Guo
LZLixin Zhang
Lixin Zhang

4 June 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CFChengzhang Fu
Chengzhang Fu
Lena KellerLena Keller
Lena Keller
ABArmin Bauer
Armin Bauer
Mark BrönstrupMark Brönstrup
Mark Brönstrup
AFAlexandre Froidbise
Alexandre Froidbise
RMRolf Müller
Rolf Müller